昌吉怎么治疗男性功能障碍(昌吉男的精液检查医院) (今日更新中)

SAN DIEGO (KGTV) — At age 41, Ryan Bartell had already achieved so much: He was a two-time all-state runner, served in the Coast Guard, and was helping autistic children alongside his wife. He also had a son of his own. “Ryan called me on March 1 of last year to say that he had been diagnosed with stage IV pancreatic cancer," remembers Jim Bartell, Ryan's father. The cancer was aggressive and chemotherapy wasn't working, Ryan was in a lot of pain. “They had him on morphine and fentanyl, two very serious opioids, and because of those two drugs he was asleep most of the time to deal with the pain," said Jim. Jim says that lasted for about four weeks until Ryan asked for cannabis. “He went from being asleep most of the time with fentanyl and morphine to being alert and being able to communicate, text, talk to friends, have visitors, while he was on the cannabis medicines."Jim says the cannabis gave Ryan a decent quality of life in his final weeks; he passed away seven weeks after the initial diagnosis. “While medical cannabis has been proven to help with reducing nausea, vomiting, and pain, hospitals in our state are expressly prohibited from providing it to patients," said State Senator Ben Hueso.Because of the Federal Drug-Free Workforce Act, hospitals have adopted policies prohibiting cannabis in their facilities. Hueso wants to change that with SB 305 or Ryan’s Law: Compassionate Access to Medical Cannabis in Healthcare Facilities Act.Healthcare facilities which treat terminally ill patients would be required to allow the use of medical cannabis, meaning patients could bring their product inside the hospital.The patient would be required to provide the facility with a copy of their medical marijuana card or recommendation by a physician.The bill excludes vaping or smoking but edibles, oils, topicals, etc. would be allowed. New York already has a similar law. “I felt something had to be done so that that didn’t happen to other people who wanted a higher quality of life near the end of their life," said Jim, who initiated the legislation. 2082

SAN DIEGO (KGTV) - Cal Fire is battling a brush fire near East San Diego County on the U.S.-Mexico border. The flames broke out after 11 a.m. near the Cottonwood Creek area off SR-94, not far from Barrett Junction. 100 acres burned in the U.S., with the fire spreading to 650 acres in total by 7:30 p.m. It is 10 percent contained.The fire has a moderate rate of spread and was burning light brush, Cal Fire confirmed to 10News. There is no immediate threat to structures, officials said.Images from an SDG&E camera appeared to show heavy smoke over the area.Check 10News Pinpoint Weather conditionsEast County is under an Excessive Heat Warning due to high pressure. Fire danger is also high through the weekend due to the threat of dry lightning, according to 10News meteorologist Megan Parry.Cal Fire has not determined the cause of the brush fire. 859

SAN DIEGO (KGTV) -- California officially has a state sport as of Monday afternoon, surfing. With all the buzz you may be wondering where you can catch some waves in San Diego County. There are tons of places throughout the county to check out, whether you're a beginner or a pro. Check out the list below for more:  339

SAN DIEGO (KGTV) — As the world waits for a vaccine against the coronavirus, two San Diego biotechs are teaming up to develop a nasal spray using designer antibodies cloned from COVID-19 survivors.About 70 companies worldwide are working on therapies for COVID-19 using cloned antibodies, according to an estimate by the International AIDS Vaccine Initiative. A few of these treatments, known officially as monoclonal antibody therapies, have advanced to clinical trials.Most require an injection, but San Diego-based Diomics and its partner Active Motif, based in Carlsbad, are developing a once-a-day spray that could be easily self-administered.Early research suggests the coronavirus primarily enters the body through the nose. The spray, called Dioguard, is designed to coat the lining of the nasal cavity with cloned antibodies that are held in place for 24 hours or more using a proprietary polymer material developed by Diomics.Diomics CEO Anthony Zolezzi said he believes the spray “holds the key to allowing many aspects of life to resume until the day comes when there’s an effective vaccine in widespread use.”Diomics is also developing two tests for COVID-19 antibodies using its polymer beads, including a device that looks like a nicotine patch that is designed to monitor for infections for a week or more.RELATED: How a dot on your forearm could be the future sign of COVID immunityActive Motif is providing the cloned antibodies for the nasal spray. With a lab in Shanghai and other relationships in China, the Carlsbad company was able to clone antibodies from 11 Chinese survivors in February, before the World Health Organization declared a pandemic.When the company started the cloning project, they thought the virus would probably disappear in three to six months, said Active Motif CEO Ted DeFrank. “Then people started realizing, no this is going to be with us for a while.”The plasma from the 11 Chinese patients contained thousands of antibodies, and scientists with Active Motif set about selecting the one that was most effective, dubbed 414-1. The company says it can neutralize SARS-CoV-2 virus particles with 98 percent effectiveness.Monoclonal antibodies have some similarities to convalescent plasma, which is a complex cocktail of antibodies and other immune molecules drawn from the blood of recovered patients. One of the key differences is that cloned antibodies can be mass produced in a lab.Cloned antibodies have been used in treatments for more than 30 years, primarily for cancer. One such treatment famously helped former U.S. President Jimmy Carter beat melanoma.But of the more than 100 monoclonal antibody therapies licensed for use, only seven are for communicable diseases, according to IAVI.Historically, the treatments have been expensive and difficult to produce, but Diomics said it’s targeting a price of about a spray for Dioguard, roughly per bottle.“We do not want to have huge profits from a pandemic, that’s just wrong,” Zolezzi said. “We’re going to price this as effectively as we can for the masses. We want to get this out to the masses.”Animal testing is about to begin and the companies said they hope to progress to human trials soon. Their goal is to release the spray in early 2021, when a vaccine may be on the market but not yet widely available.If the spray works, it could be adapted to other viruses to help fight future pandemics, Zolezzi said."That’s our real goal," Zolezzi said. "That we never get caught flat-footed like this time." 3526

SAN DIEGO (KGTV) — County public health officials say the first shipment of a potential coronavirus vaccine from drug company Pfizer will only cover about 70% of the first group of recipients identified in Phase 1.The CDC's Advisory Committee on Immunization Practices (ACIP) recommends that Phase 1A of vaccine distribution covers health care workers, and residents and workers of nursing homes and long-term care facilities:On top of that distribution structure, ACIP also split Phase 1A into three tiers to prioritize which groups of health care workers will receive a vaccine first:Tier 1:Acute care, psychiatric, and correction facility hospitalsSkilled nursing facilities, assisted living facilities, and similar settings for older or medically vulnerable individualsInclude residents in these settings as recommended for Phase 1A and ACIPParamedics, EMTs, and others providing emergency medical servicesDialysis centersTier 2:Intermediate care, for persons who need non-continuous nursing supervision, and supportive careHome health care and in-home supportive servicesCommunity health workers, including promotorasPublic health field staffPrimary care clinics, including Federally Qualified Health Centers, Rural Health Centers, correctional facility clinics, and urgent care clinicsTier 3:Other setting and health care workings, including specialty clinics, laboratory workers, dental/oral health clinics, pharmacy staff not working in settings at higher tiersAccording to San Diego County Public Health Officer Dr. Wilma Wooten, the county will only receive enough doses to cover about 70% of one group in the first tier of Phase 1A."We are not even getting enough doses for that first dot point in tier one," Wooten said, referring to acute care, psychiatric, and correction facility hospitals. "We are basically getting just over 70%."RELATED: What the FDA's review reveals about Pfizer's COVID-19 vaccineSan Diego County is expected to receive 28,275 doses of California's first allocation of 327,000 vaccine doses in mid-December. Wooten said there is about 39,000 personnel in the acute care hospital section alone."We anticipate that sometime next week, early next week, if not, on the weekend even, that we will get vaccines," Wooten said.She added that those first vaccines will be distributed to three "prepositioned locations" in the county. 2369

来源：资阳报